Bax activation and mitochondrial insertion during apoptosis

The mitochondrial apoptotic pathway is a highly regulated biological mechanism which determines cell fate. It is defined as a cascade of events, going from an apoptotic stimulus to the MOM permeabilization, resulting in the activation of the so-called executive phase. This pathway is very often altered in cancer cells.The mitochondrial permeabilization is under the control of the Bcl-2 family of proteins (pBcls). These proteins share one to four homology domains (designed BH1-4) with Bcl-2, and are susceptible of homo- and/or hetero-dimerization. In spite of a poor amino-acid sequence homology, these proteins exhibit very similar tertiary structures. Strikingly, while some of these proteins are anti-apoptotic, the others are pro-apoptotic. Pro-apoptotic proteins are further divided in two sub-classes: multi-domains proteins, among which Bax and Bak, which exhibit BH1-3 domains, and BH3-only proteins (or BOPs). Schematically, BOPs and anti-apoptotic proteins antagonistically regulate the activation of the multi-domain proteins Bax and Bak and their oligomerization in the MOM, the latter process being responsible for the apoptotic mitochondrial permeabilization.Considering the critical role of Bax in cancer cells apoptosis, we focus in this review on the molecular events of Bax activation through its interaction with the other proteins from the Bcl-2 family. The mechanism by which Bax triggers the MOM permeabilization once activated will be discussed in some other reviews in this special issue.

[1]  J. Martinou,et al.  Bax Is Present as a High Molecular Weight Oligomer/Complex in the Mitochondrial Membrane of Apoptotic Cells* , 2001, The Journal of Biological Chemistry.

[2]  John Calvin Reed,et al.  Bcl-2 family proteins as ion-channels , 1998, Cell Death and Differentiation.

[3]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[4]  Z. Oltvai,et al.  Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Martinou,et al.  Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane , 2000, Molecular and Cellular Biology.

[6]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[7]  Y. Hsu,et al.  Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Kroemer,et al.  Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XL , 2002, Oncogene.

[9]  P. Cartron,et al.  Activation of Bax by BH3 Domains during Apoptosis:The zunfolding of a Deadly Plot , 2005, Cell cycle.

[10]  S. Korsmeyer,et al.  Regulated Targeting of BAX to Mitochondria , 1998, The Journal of cell biology.

[11]  L. Ghibelli,et al.  Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  A. Petros,et al.  Structural biology of the Bcl-2 family of proteins. , 2004, Biochimica et biophysica acta.

[13]  C. Borner,et al.  Bcl‐2 is a monomeric protein: prevention of homodimerization by structural constraints , 2000, The EMBO journal.

[14]  Y. Hsu,et al.  Bax in Murine Thymus Is a Soluble Monomeric Protein That Displays Differential Detergent-induced Conformations* , 1998, The Journal of Biological Chemistry.

[15]  S. Cory,et al.  Life-or-death decisions by the Bcl-2 protein family. , 2001, Trends in biochemical sciences.

[16]  P. Cartron,et al.  Mitochondria as the target of the pro-apoptotic protein Bax. , 2006, Biochimica et biophysica acta.

[17]  T. Tsuruo,et al.  NH2-terminal BH4 Domain of Bcl-2 Is Functional for Heterodimerization with Bax and Inhibition of Apoptosis* , 1999, The Journal of Biological Chemistry.

[18]  Interaction with a Membrane Surface Triggers a Reversible Conformational Change in Bax Normally Associated with Induction of Apoptosis* , 2003, Journal of Biological Chemistry.

[19]  S. Fesik,et al.  Bcl‐xL regulates apoptosis by heterodimerization‐dependent and ‐independent mechanisms , 1999, The EMBO journal.

[20]  K. Muegge,et al.  Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Cartron,et al.  Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment , 2003, Expert review of anticancer therapy.

[22]  Nico Tjandra,et al.  Structure of Bax Coregulation of Dimer Formation and Intracellular Localization , 2000, Cell.

[23]  I. Mingarro,et al.  Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores , 2006, The FEBS journal.

[24]  S. Korsmeyer,et al.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. , 2002, Cancer cell.

[25]  H. Yamaguchi,et al.  Lipidic Pore Formation by the Concerted Action of Proapoptotic BAX and tBID* , 2004, Journal of Biological Chemistry.

[26]  P. Cartron,et al.  The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. , 2002, Human molecular genetics.

[27]  D. Andrews,et al.  Bcl‐2 changes conformation to inhibit Bax oligomerization , 2006, The EMBO journal.

[28]  Y. Hsu,et al.  Conformation of the Bax C‐terminus regulates subcellular location and cell death , 1999, The EMBO journal.

[29]  D. Green,et al.  Minimal BH3 Peptides Promote Cell Death by Antagonizing Anti-apoptotic Proteins* , 2003, Journal of Biological Chemistry.

[30]  E. Pérez-Payá,et al.  Membrane-insertion fragments of Bcl-xL, Bax, and Bid. , 2004, Biochemistry.

[31]  Jean-Claude Martinou,et al.  Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. , 2002, The Biochemical journal.

[32]  J. Martinou,et al.  Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. , 2000, The Biochemical journal.

[33]  John Calvin Reed,et al.  The Putative Pore-Forming Domain of Bax Regulates Mitochondrial Localization and Interaction with Bcl-XL , 2000, Molecular and Cellular Biology.

[34]  M. Priault,et al.  The N-terminal End of Bax Contains a Mitochondrial-targeting Signal* , 2003, The Journal of Biological Chemistry.

[35]  C. Borner,et al.  The Binding Properties and Biological Activities of Bcl-2 and Bax in Cells Exposed to Apoptotic Stimuli* , 1998, The Journal of Biological Chemistry.

[36]  T. Mitchison,et al.  Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL , 2001, Nature Cell Biology.

[37]  P. Cartron,et al.  Distinct Domains Control the Addressing and the Insertion of Bax into Mitochondria* , 2005, Journal of Biological Chemistry.

[38]  C. Milliman,et al.  BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.

[39]  John Calvin Reed,et al.  Heterodimerization-independent Functions of Cell Death Regulatory Proteins Bax and Bcl-2 in Yeast and Mammalian Cells* , 1997, The Journal of Biological Chemistry.

[40]  E. Mayat,et al.  Involvement of the N‐terminus of Bax in its intracellular localization and function , 2002, FEBS letters.

[41]  F. Maxfield,et al.  The Distal Pathway of Lipoprotein-induced Cholesterol Esterification, but Not Sphingomyelinase-induced Cholesterol Esterification, Is Energy-dependent* , 1996, The Journal of Biological Chemistry.

[42]  C. Dive,et al.  Mitochondrial membrane permeabilisation by Bax/Bak. , 2003, Biochemical and biophysical research communications.

[43]  David A Hildeman,et al.  ×Phosphorylation of Bax Ser184 by Akt Regulates Its Activity and Apoptosis in Neutrophils* , 2004, Journal of Biological Chemistry.

[44]  D. Andrews,et al.  Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis , 2005, The EMBO journal.

[45]  S. Sebti,et al.  Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction. , 2005, Journal of the American Chemical Society.

[46]  E. Mayat,et al.  Impact of pH on Bax α conformation, oligomerisation and mitochondrial integration , 2004 .

[47]  Jean-Claude Martinou,et al.  Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis , 1999, The Journal of cell biology.

[48]  Y. Hsu,et al.  Nonionic Detergents Induce Dimerization among Members of the Bcl-2 Family* , 1997, The Journal of Biological Chemistry.

[49]  Yi-Te Hsu,et al.  Movement of Bax from the Cytosol to Mitochondria during Apoptosis , 1997, The Journal of cell biology.

[50]  S. Korsmeyer,et al.  Mutagenesis of the BH3 Domain of BAX Identifies Residues Critical for Dimerization and Killing , 1998, Molecular and Cellular Biology.

[51]  Mason R. Mackey,et al.  Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane , 2002, Cell.

[52]  B. Corfe,et al.  Damage‐induced Bax N‐terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate , 2001, The EMBO journal.

[53]  Y. Hsu,et al.  Bcl‐xL sequesters its C‐terminal membrane anchor in soluble, cytosolic homodimers , 2004, The EMBO journal.

[54]  Philippe Juin,et al.  The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. , 2004, Molecular cell.

[55]  John Calvin Reed,et al.  Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2 (*) , 1996, The Journal of Biological Chemistry.